cryptoscott retweeted
‼️ UPDATE: The hackers who planted malware in Microsoft's AI agent toolkit on PyPI pushed it through Microsoft's own release system, with a stolen Microsoft certificate and private key.
Cloud security firm Wiz says their first try, from AWS, was blocked. The second, from a Microsoft-owned network, went through.
How the key was stolen is not yet known. Wiz counted three confirmed thefts of victim data before both versions were pulled within the hour.
The attackers' own AI hacking tool gave part of the operation away, reporting its progress to the same web address the stolen data went to.
cryptoscott retweeted
BREAKING: The European Commission has been hit by a major cyberattack that may have exposed large amounts of staff personal data, per Politico.
The Commission has taken several systems offline, including tools staff use to check payslips, track working hours, request leave and process medical reimbursements. The attack has been going on for about 10 days. Technology chief Henna Virkkunen briefed fellow commissioners at their weekly meeting on Wednesday.
The EU’s cybersecurity team, CERT-EU, reportedly found the attackers used a freely available AI tool to scan for weaknesses in the Commission’s systems.
cryptoscott retweeted
BREAKING: Global fund managers cut their technology exposure by -25 percentage points in early November, to a net 12%, their biggest monthly decline since June 2006.
This marks even a larger monthly decline than during the 2022 bear market or the 2008 Financial Crisis.
As a result, technology is no longer the most overweight sector among fund managers.
The largest overweight positions are currently in Pharmaceuticals, at 34%, and Industrials, at 19%.
A record 38% of surveyed institutional investors believe companies are overinvesting, up from ~20% in January.
At the same time, 52% expect Big Tech companies to announce CapEx reductions over the next 6 months, up from 30% in October.
Institutional investors are rotating out of technology stocks at a rapid pace.
cryptoscott retweeted
Bringing Salesforce to Copilot as we build Copilot as the OS for work!
Introducing Copilotforce
Salesforce customer context and sales workflows are coming to @MSFTCopilot and @MicrosoftTeams—where more than 400M people already collaborate
Our expanded partnership with @Microsoft spans Copilot, Teams & Fabric:
→ Salesforce in Microsoft Copilot will help sellers prepare for meetings, spot deal risks & take supported Salesforce actions, informed by customer context, emails, meetings & shared documents
→ @SalesCloud in Teams will bring pipeline insights, deal alerts & supported opportunity updates into Teams, with Agentforce Coworker helping sellers delegate work & take action
→ Data 360 + Microsoft Fabric connect through bidirectional zero copy, so teams can access data across both platforms without duplicating source datasets
→ @Informatica expands its Microsoft integrations to help teams find trusted data in Copilot, build governed AI agents in Foundry & trace data lineage in Fabric
@Accenture joins as Customer Zero and design and implementation partner to help shape and validate Copilotforce within its global sales organization, after scaling Microsoft Copilot to 740,000+ people
See what’s new from #MSIgnite: sforce.co/4kgw4iZ
cryptoscott retweeted
NEWS: Wall Street execs and NSA have told Congress that outages were caused by patching vulnerabilities identified by AI models, sources say
AI did not cause outages but found so many issues that the rush to fix them before an attack overwhelmed systems
washingtonsun.com/technology…
cryptoscott retweeted
Rand Group estimates annualized cyber incidents have nearly tripled in six months, from 3,500 to almost 10,000, following the launches of GPT-5.5 and Claude Fable 5.
Every bank has people capable of extraordinary work.
Yet most of them are stuck navigating painful old systems.
Those same systems are what hold AI back. On a modern stack, AI can do real work, and @StitchHQ now has it built in:
- A copilot that does the work, not just the talking.
- A banking-grade harness to natively embed your own agents.
- Ready-made agents that drop into your existing workflows.
All within the limits your bank sets. So your team gets to do the work it's capable of, with the tools they deserve.
PS: I heard central banks now ask Jeff to audit them.
From @altcap thesis on Anthropic
- Estimating $86B ARR EOY
- Getting $1T ARR is just 4% knowledge work
- Anthropic primarily allocates to training frontier models
- FASTEST growing co of all time… gonna eclipse Meta and Google
- may hedge his public book given public books are volatile.
You crushed it Brad. Great f***ing intro to fire people up
Brad $ANT Thesis:
- Google had 105k people to get to $100B revenue
- Anthropic needs 5k people to get to $100B revenue
- the 100K people Google had, Anthropic can allocate the human cost to compute
cc @altcap @AltimeterCap @TomorrowXSummit
cryptoscott retweeted
5 MAJOR DISRUPTIONS IN JUST 6 DAYS
🇺🇸 Nov 17: NSA classified network DOWN
🏦 Nov 16: JPMorgan banking failure
✈️ Nov 16: United Airlines outage
🛑 Nov 13: FAA nationwide ground stop
🌐 Nov 12–13: Microsoft 365 outage
No coordinated cyberattack confirmed.
cryptoscott retweeted
It's still only Monday.
BREAKING: Google says “the era of autonomous attacks has arrived.”
Hackers are now using AI to scan software updates, figure out which security flaw each patch fixes and build an attack before companies can install the fix, all without a human involved, according to a new report from the Google Threat Intelligence Group.
“Defending against machine-speed threats at human speed isn’t feasible,” Google said.
cryptoscott retweeted
‼️ UPDATE: Microsoft says last week's global Microsoft 365 outage came from a fix it rolled out in July, which hid a bug for over three months.
The bug froze the gateway servers in front of Exchange Online email and other Microsoft 365 services under heavy load. Lab tests on weaker machines missed it.
Hours earlier, Teams had moved its traffic onto those servers, while nearly 14% were already offline.
Microsoft's automatic failover then spread it. In under two hours, more than 80% of the servers stopped responding.
Servers that came back were flooded by waiting traffic and froze again.
Biggest winner of Jensen leaving: Anthropic IPO.
TL:DR Before Jensen outster, biggest threat to ANT / OAI was ...open source models. Now w/o Jensen, I believe open source market share of enterprise token spend just dropped from 50% in 2030 down to 10% (inability to get compute / chips will slow down research) and $ANT to maintain market share at >50% through 2030 which is V bullish for IPO this Thursday.
Simply put, if you believe there will be $3T of AI spend (today its $180B in 2026) by enterprises in 2030, that's $1.5T for ANT.
Jensen first tweet on X, ever, was on why open source models matter.
Now a week before the $ANT IPO, Jensen is out and the biggest threat for ANT / OAI, open source models, have lost a major champion and a competitor in NeMo that Jensen wanted to compete against Opus.
In Sept'26 when I put out my Anthropic model at $1T ARR in 2030, my core fear was open source models could become just as good and cheaper -- why pay a premium for Opus / Mythos / Fable.
We saw that at Artemis using @OpenRouter for our Analyst -- we were moving spend from $ANT to cheaper / faster models.
In Sept '26 my view was 50% of enterprise token spend was going to shift to open source due to customizability, open weight, lower cost, etc which hurts Anthropic.
In Oct '26, I revised my estimates down to $500B ARR b/c of open source / OAI Astra taking share / AI safety concerns and general contraction in AI spend in Q3'26.
Now post Jensen leaving, I believe enterprise token spend on open source won't be more than 10% (its 4% today in 2026 according to @MenloVentures ) and Anthropic can maintain >50% marketshare.
I'm updating my model with my base case now is $1.5T - $2T ARR for 2030 as OAI / ANT really win from a more closed source regime.
More on the updated thesis / model soon.
For my first post, I’m sharing a letter @NVIDIA signed on why open models matter.
AI will transform every industry, power every company, and be built by every country.
Open models strengthen safety and cybersecurity, accelerate innovation and diffusion, and enable sovereignty.
The world needs both frontier closed models and frontier open models.
images.nvidia.com/pdf/Open-W…
Wiz co-founder and CTO Ami Luttwak says AI can now carry out cyberattacks in 20 minutes that once took skilled attackers weeks or months.
In his view, companies need to continuously attack their own systems with the latest AI models to stay secure. For startups, that means building automated testing and patching into the development process from the beginning.
Ami joins a16z's Sarah Wang and Zane Lackey to discuss what changed during Black October, why patching is falling behind, the cost of continuous security testing, and why better security architecture matters more than simply buying more tools.
0:00 Intro
1:04 Welcome to Black October
3:19 How AI made every day a zero day
6:51 The PHP vulnerability: 70% of the internet
9:19 Why patching can't keep up
11:32 How Wiz uses AI to find vulnerabilities
16:59 The cost of continuous testing
19:23 Cloud security in the AI era
22:18 The red agent: attack yourself first
26:41 Agent swarms attacking your own systems
28:43 What founders must do before they ship
32:15 Where security budgets should go
36:10 Most of what security teams do isn't security
43:34 Scan for Good and public infrastructure
YouTube: youtu.be/PbD9pVXxsYM
@amiluttwak @sarahdingwang @zanelackey
cryptoscott retweeted
If you somehow missed last month's hedge fund bloodbath, I sat down with @tracyalloway & @TheStalwart on their amazing Odd Lots podcast to try and unpack what happened, why it happened so fast and what it means for roughly 35 trading days left this year podcasts.apple.com/us/podcas…
NEW ODD LOTS:
A brutal 5 weeks for hedge funds of all types.
@tracyalloway and I talk to @nishantkumar07 about all these funds posting terrible numbers and then we also talk to Bloomberg News’ Michael Ball about what’s driving these huge market moves podcasts.apple.com/us/podcas…
cryptoscott retweeted
Barclay’s recent check is slightly better than my check three weeks ago
What master bubble boi talked about is pretty consistent with what I heard from a VC friend last night:
Q4 revenue 18.5B due to headwind from seasonality and distillation block. So this translates to year end ARR as 80B+ roughly? Pretty disappointing and thanks to Opus 5.5 for accelerating the growth.
2027/2028 135/270b revenue run rate, which translates to 200B ARR 2027E I believe, also not high enough to beat sell side expectations?
Also heard that my margin expansion thesis wouldn’t last in 2027 unfortunately due to capex expansion.
Anyway my original thought of “Anthropic S1 saves AI trades” seems not going to happen. But let’s wait for next week to see how the Mr Market reacts when the real S1 file goes public.
cryptoscott retweeted
ServiceNow is laying people off left and right while also clawing back sales commissions to cut costs.
They were dumb enough to start with Enterprise first, so now their lower tier reps are temporarily making more money than anybody else in the company.
SERVICENOW IS CUTTING AGAIN. THIS IS THE THIRD ROUND THIS YEAR.
Employees in the US, the UK and India are being notified, according to CTech and NowBen. ServiceNow has not said how many roles are going.
What we can lock from the books: severance and related costs hit $167 million in the first nine months of 2026, up from $53 million a year earlier. The third quarter alone was $87 million.
The stock fell about 27% the day after Q3 guidance missed Wall Street, and is down about 35% from Oct. 23 through Nov. 5. The company still says it wants to end 2026 with roughly the same headcount it started with, while hiring into AI-focused skills.
cryptoscott retweeted
The best portfolio managers I observed in my old W2 life knew what stocks would work in different tapes. Being dogmatic on valuation was a recipe for many portfolio managers to hit stop losses.
I remember when I started my career at multi strats I would hear senior PMs say “yeah that’s not going to work in this tape” and thinking what kind of clown show is that when their analyst had done a ton of fundamental work. These senior PMs were the ones to never have down years and always put up consistent P&L - great risk managers (would be terrible analysts as not as good on deep fundamentals work) that just “got it”
nitter.cf/Mr_Derivatives/status/…
WHO WANTS THE UPDATED ANTHROPIC MODEL?!
cc @zhengjielimm
HERE'S THE ANTHROPIC MODEL: Anthropic will go public at $2T in Oct '26 and will be a $1T ARR company and $10T+ company Dec' 2030 as the winner of AI.
Here's how Anthropic gets to $1T ARR in 2030:
- 2026E: $125B ARR +14x YoY w/ 5 GW live
- 2027E: $266B ARR + 114% YoY w/ 10 GW live
- 2028E: $462B ARR +73% YoY w/ 16 GW live
- 2029E: $700B ARR +52% YoY w/ 23 GW live
- 2030E: $1T ARR + 42% YoY w/ 30 GW live
I'm dropping my full Excel model modeling out:
- ARR by business model (e.g Consumer, B2B, Enterprise, API)
- API business broken down by model type (e.g Fable 5.1, Mythos, Opus, Sonnet)
- Training costs and inference cost as a % of revenue
- Gross Margin ($ ARR per MW and Cost of Compute per MW) as well as forecasting GW secured.
- Net ARR (vs Gross ARR reported by trackers) removing marketplace pay out, Meta, Chinese AI labs
- and more
I also share the @artemis thesis for WHY Anthropic is the AWS of AI and winner of AI in the enterprise (and open source and ANT / OpenAI can win)
Get the full model here: artemis.ai/anthropic-thesis
Full Disclosure: I don't have inside information. I took what's publicly available from the July '26 @SemiAnalysis_ model and added my own judgement based on public information and my own world views. I've spent a life time modeling as a former HF and VC analyst. I'll update the model as soon as the S-1 drops.
cryptoscott retweeted
It's remarkable how tied at the hip the sentiment and performance of Databricks and Snowflake's sales orgs are (see the 5 year chart of percent of quota carrying sellers able to get to quota). Two points to watch:
Just in the past several months Databricks' sales org size has passed Snowflake's in terms of headcount. Let's see if their momentum continues with the capacity increases continuing.
There's been a separation in the sentiment of inbound lead flow with SNOW going up relative to Databricks going down...
Replying to @RamaswmySridhar
I don't think we should fight. The two companies are complementary. Since you're not doing this AI stuff, I really think Snowflake should consider getting its AI tokens through Databricks. You can get both cheap OSS models as well as frontier (OAI/Ant/Gemini/Grok) models from our platform. It all goes through Unity Gateway which has Smart Routing, Budgets, and Access Control. You can even use Omnigent with any harness, including CoCo. Most of our customers used this to reduce token spend ~30% last few months while token count went up. Genie lets you then track, control, manage that spend, all your financials, marketing, etc. Quick POC?
cryptoscott retweeted
Claude Science looks to me like a bid to own the economic version control system for life sciences. The logical endgame is Anthropic financing hundreds of drug programs in parallel for the biopharmas that leverage its harness. In return, Anthropic will ask for clinical data rights and use the data generated to 1) improve their ability to finance the next program and 2) eventually feed a God Model that allows them to create the holy grail: an “AI drug factory”.
You can think of a drug program as an exercise in making a sequence of complex decisions under uncertainty: specifically, decisions around how to allocate incremental experimental capital to maximize expected value across safety, efficacy, commercialization, etc.
A growing share of that experimental capital will be compute-mediated over time (e.g, Claude generated roughly 35,000 antibody designs in a month for Divergence Labs). But the most consequential increments will still go toward compiling therapeutic candidates in (very scarce and slow) human biological computers, which is where both the cost per bit and the consequentiality per bit of information are highest.
Whoever owns the system that originates and integrates the most information upstream and downstream of those allocation decisions (in this case Anthropic) becomes the best suited to start making them (or at least gains a differentiated understanding of the relevant signals necessary to make those decisions well).
Some examples of the experimental capital allocation decisions they are starting to help generate / facilitate and version:
1) Most importantly: Acquiring Mithril, where Cody Tranbarger (@prof_oak_) is massively levered by a swarm of agents that help him identify, evaluate, and ultimately select a much larger # of drug programs to run in parallel than is typically possible for a single drug hunter. He calls this a “Pipeline-in-a-Person”
2) Bristol Myers using Claude Science to analyze their proprietary data (guessing preclinical and clinical) to create optimal clinical study plans and weigh the study’s chance of success. If that program is actually executed, they should be able to calibrate how well those predictions turned out and in what sense they were right or wrong.
3) The Column Group spinning up Pleiades: a biopharma company with a mandate to “run many more—and more complex—drug programs than is usual for a small team.” Similar to the Formation Bio’s of the world. They are using Claude to evaluate target-disease pairs and find non-obvious, potentially valuable combinations.
I believe Anthropic is running their own drug programs not to compete with pharma directly (yet), but instead to generate the learning signals that would allow them to become the single largest (and potentially best calibrated) underwriter / financier of drug programs. These financed programs would eventually create the data distributions necessary for them to create an AI drug factory (and start competing with pharma).
Specifically, I could see Anthropic creating the first real instantiation of @AndrewWLo’s elegant Megafund model. TLDR on Megafund (proposed in Nature Biotechnology 14 years ago): any single drug program is a terrible bet on its own, but if one entity funds a large enough portfolio of them, the odds that a few hit become predictable enough to finance the whole thing with debt. Lo et al. proposed doing this by issuing “research-backed obligations” (bonds collateralized by the portfolio and its IP) alongside an equity tranche. Ofc, the pool of available capital that buys debt is far larger than the pool that buys biotech equity, therefore this would unlock capital from pensions, insurers, endowments, etc. Their simulations of $5–15 billion oncology portfolios estimated average annual returns of 8.9–11.4% for the equity and IMPORTANTLY 5–8% for the RBOs. This would be a fixed-income-like return that many new sources of capital would get excited about.
For some reason this strategy never took off, and part of the reason is that it’s pretty hard to find a large basket of drug programs that’s sufficiently uncorrelated. But I also think it’s because there wasn’t really an incentive for any well capitalized player to push through all the schleps and actually unlock the capital sources to this end. I think Anthropic has that incentive.
They have a structurally higher willingness to finance a drug program / make this structure real, because, by doing so, they would capture two return streams: 1) the potential economics of a blockbuster drug and 2) the widely amortizable value of what the associated series of experimental capital allocation decisions teach its models!
In return for providing biopharmas cheap financing, Anthropic will ask for clinical data rights (including rights to learn from decision histories, negative results, protocols, etc.). Just selling tokens / the harness doesn’t give them the right to learn all of these things, but providing financing likely would.
This would allow them to make more well-calibrated experimental capital allocation decisions over time and eventually feed the God Model that “cures all disease.”
This would all also be quite charismatic: your retirement money funds the experiments that might let you enjoy a much longer retirement!
Over the past few months, Anthropic scientists have engaged in deep research partnerships with six organizations developing new medicines. We've also begun drug discovery efforts of our own.
In doing so, we’ve learned much more about how Claude can support the many stages of drug development.
In this blog post, we share some early results from these efforts, and describe how this work fits in with our wider ambitions in the life sciences.
anthropic.com/research/early…


















































